Amsurg Corp. (NASDAQ:AMSG) shares traded down 3.1% on Tuesday . The stock traded as low as $62.88 and last traded at $63.01, with a volume of 746,022 shares changing hands. The stock had previously closed at $65.04.

A number of research firms have commented on AMSG. Zacks Investment Research raised shares of Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 target price on the stock in a research report on Monday, July 11th. Wells Fargo & Co. began coverage on shares of Amsurg Corp. in a research report on Tuesday, June 14th. They issued a “market perform” rating on the stock. Robert W. Baird reaffirmed a “buy” rating on shares of Amsurg Corp. in a research report on Thursday, June 16th. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Amsurg Corp. in a research report on Friday, June 17th. Finally, Bank of America Corp. raised shares of Amsurg Corp. from a “neutral” rating to a “buy” rating and set a $104.00 target price on the stock in a research report on Thursday, June 16th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $93.90.

The firm has a market cap of $3.49 billion, a price-to-earnings ratio of 19.261 and a beta of 0.65. The stock has a 50 day moving average of $66.09 and a 200 day moving average of $73.81.

Amsurg Corp. (NASDAQ:AMSG) last announced its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.02. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The business earned $758.50 million during the quarter, compared to analysts’ expectations of $769.88 million. During the same quarter last year, the business posted $0.97 earnings per share. The business’s revenue for the quarter was up 21.5% on a year-over-year basis. Equities analysts expect that Amsurg Corp. will post $4.33 EPS for the current fiscal year.

In related news, insider Robert Jon Coward sold 7,500 shares of Amsurg Corp. stock in a transaction dated Thursday, August 18th. The stock was sold at an average price of $64.36, for a total transaction of $482,700.00. Following the completion of the sale, the insider now owns 105,007 shares in the company, valued at approximately $6,758,250.52. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 2.30% of the stock is owned by insiders.

A number of hedge funds have recently bought and sold shares of the company. Emerald Acquisition Ltd. bought a new stake in Amsurg Corp. during the second quarter worth approximately $106,000. Smith Asset Management Group LP boosted its stake in Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock worth $133,000 after buying an additional 1,700 shares in the last quarter. Invictus RG boosted its stake in Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock worth $142,000 after buying an additional 1,698 shares in the last quarter. Checchi Capital Advisers LLC bought a new stake in Amsurg Corp. during the second quarter worth approximately $157,000. Finally, Advisor Group Inc. bought a new stake in Amsurg Corp. during the second quarter worth approximately $202,000. Hedge funds and other institutional investors own 98.42% of the company’s stock.

Amsurg Corp. Company Profile

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

5 Day Chart for NASDAQ:AMSG

Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.